Article processing charges (APCs) support peer review coordination, editorial management, production, DOI registration, and long term archiving. APCs are applied after acceptance and do not influence editorial decisions.

JAA is committed to transparency and affordability for authors in antioxidant research communities.

• Editorial assessment and peer review management
• Copyediting, layout, and publication production
• DOI registration and metadata validation
• Long term archiving and platform maintenance
• Open access hosting and global dissemination

Authors from World Bank classified low income and lower middle income countries may be eligible for partial APC waivers. Requests are evaluated on a case by case basis and must be submitted before acceptance.

Membership options offer discounted APCs for eligible authors and institutions. Contact the editorial office for guidance.

To avoid delays, payments should be completed within 48 hours of invoice receipt. Publication proceeds after payment confirmation.

JAA is committed to rigorous, transparent publishing in antioxidant science. We emphasize reproducible methods, complete data statements, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in antioxidant research.

If your institution requires invoice language or grant identifiers, provide them before acceptance to avoid delays.

APC receipts include journal name, manuscript title, and DOI reference for institutional reporting.

Payment can be made by institutions, funders, or authors. Coordinate billing details early to streamline processing.

Requests for partial waivers should be submitted before acceptance with supporting documentation.

APCs support long term digital preservation and open access distribution of antioxidant research.

If a funding agency requires open access confirmation, the editorial office can provide verification after publication.

Invoices can be issued to a central grants office when funding sources require consolidated billing.

APC questions are handled by the editorial office; contact them early to align budgets with publication timelines.

Include a concise summary of antioxidant mechanisms studied, such as radical scavenging, metal chelation, or enzyme modulation, so readers can quickly understand the biological focus of the work.

Report assay conditions in detail, including concentrations, incubation times, and reference standards, to ensure that antioxidant activity can be reproduced and compared across studies.

When using cell based or in vivo models, clarify dosing, bioavailability considerations, and how antioxidant outcomes were quantified relative to controls.

If multiple antioxidant assays are used, explain how results are integrated and whether assays measure distinct mechanisms or overlapping effects.

Describe how oxidative stress biomarkers were selected, measured, and validated, especially when translating findings to clinical or nutritional contexts.

Provide clear statements about sample sourcing, extraction methods, and compound purity for plant or food derived antioxidants.

Discuss limitations such as assay specificity, matrix effects, or variability between biological replicates to help readers interpret results responsibly.

When reporting comparative studies, explain why certain antioxidants or formulations were chosen and how they align with current literature.

Highlight any translational implications, including potential therapeutic, dietary, or preventive applications, while avoiding overstated claims.

If data or code are restricted, describe access pathways and provide sufficient methodological detail to enable independent verification.

Use consistent terminology for reactive oxygen species, reactive nitrogen species, and redox pathways to avoid ambiguity across interdisciplinary audiences.

Include descriptive figure captions that explain assay outcomes and statistical significance without requiring readers to infer details from the main text.

Explain how antioxidant stability, storage conditions, or degradation was managed during experiments and analysis.

When reporting clinical or human studies, clarify participant selection, inclusion criteria, and ethical approvals relevant to antioxidant interventions.

If the manuscript involves food or nutraceutical formulations, provide composition details and quality control procedures.

Early communication with the editorial office can help confirm scope fit and avoid delays during initial screening.

State whether antioxidant activity was normalized to protein content, cell count, or sample mass to improve comparability across studies.

Report the chemical identity, purity, and source of antioxidant compounds, including catalog numbers when available.

If results rely on spectrophotometric assays, specify wavelengths, calibration curves, and baseline corrections used in analysis.

Describe how oxidative damage markers such as lipid peroxidation or DNA oxidation were quantified and interpreted.

Include positive and negative controls such as ascorbic acid, trolox, or untreated samples to contextualize assay performance.

If reactive oxygen species were measured, note probe limitations and provide validation for assay specificity.

For animal models, report species, strain, sex, age, and housing conditions to support reproducibility and ethical transparency.

When dietary interventions are used, describe diet composition, dosing schedule, and compliance monitoring methods.

Explain statistical approaches for multiple comparisons and how significance thresholds were determined for antioxidant outcomes.

Discuss how matrix effects or sample complexity may influence assay sensitivity and interpretation.

If antioxidant activity is compared across extracts, describe extraction yields and solvent systems used.

Provide clarity on whether assays measure direct radical scavenging, metal chelation, or enzyme modulation to avoid over interpretation.

When translating findings to clinical relevance, explain dose equivalence and limitations of extrapolation.

Describe any stability testing or shelf life analysis for antioxidant formulations used in the study.

If the study involves omics data, provide links to repositories and explain how oxidative stress pathways were analyzed.

Include a brief statement on how findings align with current consensus on antioxidant efficacy and limitations.

Report any adverse effects or toxicity observations related to antioxidant interventions, even if none were observed.

When presenting combination therapies, describe synergy evaluation methods and how interactions were assessed.

Clarify funding sources related to antioxidant products or supplements to avoid perceived conflicts of interest.

Provide a short summary of practical implications for clinicians, nutritionists, or industry practitioners where appropriate.